Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination.
about
Expression library immunization to discover and improve vaccine antigens.Processing of tumor antigen differentially impacts the development of helper and effector CD4+ T-cell responsesThe efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.Fusion of ubiquitin to HIV gag impairs human monocyte-derived dendritic cell maturation and reduces ability to induce gag T cell responses.Ubiquitin conjugation of hepatitis B virus core antigen DNA vaccine leads to enhanced cell-mediated immune response in BALB/c mice.Approaches to enhance the efficacy of DNA vaccines.Targeting plasmid-encoded proteins to the antigen presentation pathways.Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted NefThe immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.Regulation of Immunogen Processing: Signal Sequences and Their Application for the New Generation of DNA-VaccinesIdentification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes.The future of human DNA vaccinesTargeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimenOxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme's performance in gene immunization.Expression, Polyubiquitination, and Therapeutic Potential of Recombinant E6E7 from HPV16 Antigens Fused to Ubiquitin.
P2860
Q30833383-ED0943BB-49A3-4BEF-89B3-3BA16EB01886Q33930126-B7633372-D91A-42D7-99C2-004198A94663Q34482074-D09D6B56-222B-4771-890F-B49E2B82D029Q35088691-7527754C-2F33-4DC2-AAFC-73D789B9B3C4Q35582436-EA4717FF-5674-4BB9-890F-F096D0A3B7DCQ35743279-512B6534-C396-4885-9657-C243BCBF90F4Q35826370-91F7CF6E-0EB5-4592-92F7-E53425898DEAQ35849445-1F41BBB4-2C5A-4D26-B704-3F54254C6891Q35867988-6C8368FD-3D79-4CCE-A333-340CCD7CF0BBQ35944304-7924E15C-6A09-4EA1-B525-17074754DD7FQ36397255-B9CAAC4E-DE17-4BD8-A373-2BFE80B4B862Q36438236-ECBCB22E-751A-4A64-8CB1-4F0AB6BF6DB6Q37107624-046DFC2C-A653-4EC0-ABA8-761E0B516C7EQ37242521-642D82F4-2A4B-4279-A222-4321D153D1B5Q37530475-3197C996-400D-4FE2-A467-6F3D4765BBADQ40394482-0B98B82C-0762-4C10-8562-DC81BEEE974A
P2860
Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Targeting of hepatitis C virus ...... responses to DNA vaccination.
@en
Targeting of hepatitis C virus ...... responses to DNA vaccination.
@nl
type
label
Targeting of hepatitis C virus ...... responses to DNA vaccination.
@en
Targeting of hepatitis C virus ...... responses to DNA vaccination.
@nl
prefLabel
Targeting of hepatitis C virus ...... responses to DNA vaccination.
@en
Targeting of hepatitis C virus ...... responses to DNA vaccination.
@nl
P2093
P356
P1433
P1476
Targeting of hepatitis C virus ...... responses to DNA vaccination.
@en
P2093
P304
P356
10.1089/104454999315024
P577
1999-08-01T00:00:00Z